Wettability of Contact Lenses With a Multi-Purpose Solution

Vision Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00713076
• Other study ID #: C-07-18
• Status: Completed
• Phase: N/A
• First received: June 18, 2008
• Last updated: August 18, 2014
• Start date: October 2007

Study information

• Verified date: July 2008
• Source: Alcon Research
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Measure wettability of hydrogel and silicone hydrogel contact lenses presoaked in a Multi-Purpose Solution.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. primary completion date: March 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subjects with normal eyes who have successfully worn contact lenses on a daily basis for at least two weeks prior to the study.

• Must be wearing lenses a minimum of eight hours a day

• Vision must be correctable to 20/30 (snellen) or better in each eye at a distance with soft contact lenses

• Use no topical ocular OTC or prescribed ocular medication

Exclusion Criteria:

• Subjects with current lid or conjunctival infections, abnormalities, inflammation, abnormal corneal opacities, significant lenticular inclusions, iritis, ocular disease or condition, corneal surgery, cataract surgery, intraocular lens implants, or glaucoma filtering surgery.

• Subjects using systemic medications, upper respiratory infections or colds, history of seasonal allergies with significant ocular side effects

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Vision

Intervention

Other:
• Polyquaternium-preserved Multi-purpose Lens Cleaning Solution 109182
Lens Cleaning Solution Formulation Identification Number 109182

Locations

Country	Name	City	State
United States	Contact Alcon Call Center for Study Locations	Fort Worth	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Alcon Research

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lens Wettability - ex-vivo wetting angle		From baseline	No
Secondary	Slit-lamp findings Corrected visual acuity (snellen) Adverse events		From baseline	No